The Colts believe Jones can run back the type of performance that sparked their 8-2 start last year. The key for Jones will be understanding not just how his Achilles is progressing but also how he's otherwise tweaking any mechanics.
From Daniel Jones and Anthony Richardson to vaunted CB tandem, 4 takeaways from Colts training camp
Daniel Jones's progress with his Achilles injury and overall mechanics are being monitored by the Colts, who hope he can replicate his strong performance from last year.
Scoring Zone's Take
Daniel Jones is on the radar for a modest but real concern heading into draft season: the Colts are actively monitoring his recovery from an Achilles injury alongside his overall mechanics. That dual focus — health and technique — tells you Indianapolis isn't taking his QB1 role for granted, even though the hope is he can replicate last year's strong stretch. For fantasy purposes, this is a moderate red flag rather than a crisis; Achilles injuries can linger and affect mobility, pocket movement, and durability, all of which matter for a quarterback who has leaned on rushing production in the past.
For draft prep, treat Jones as a value play with variance attached. If he's fully cleared and mechanics look clean in camp, he could return solid QB2 or flex-worthy fantasy value given his rushing upside. But until you see him practicing without limitations and hear clearer language than "monitoring," his ADP should reflect some risk discount. Don't reach for him early — let him fall to a range where the downside (a setback, snap-count limits, or a mechanics-driven efficiency dip) doesn't sting your draft capital.
Actionable takeaway: keep Jones on your watch list as a mid-to-late round dart throw at QB, not a locked-in starter. Monitor Colts training camp reports closely over the next few weeks — any hint of a setback with the Achilles or continued mechanical inconsistency should push him down your board, while a clean bill of health restores his ceiling. Confidence here is moderate; the sourcing is consistent but vague on severity and timeline, so treat this as a hold-and-watch situation rather than a definitive downgrade.